MAX Chat
China Resources Pharmaceutical Group Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
9/10
|
9.89 | -27.77 | -135.6% | 8.69 | +13.73% |
| P/S |
|
0.1286 | 54.94 | -99.77% |
|
|
| P/BV |
|
0.3377 | 3.06 | -88.98% |
|
|
| P/FCF |
|
2.28 | 15.9 | -85.66% |
|
|
| Ev/Ebitda |
|
4.65 | 28.92 | -83.93% |
|
|
| Ev/S |
|
0.3276 | -0.5462 | -159.98% |
|
|
| Ev/FCF |
|
5.89 | -7.03 | -183.74% |
|
|
| E/P |
|
0.1026 | 0.0191 | 438.34% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
2/10
|
6.16 | -262.41 | -102.35% | 5.69 | +8.18% |
| ROE |
|
7.11 | -5.11 | -239.33% |
|
|
| ROA |
|
1.33 | 0.2788 | 376.44% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
1.3 | -266.12 | -100.49% |
|
|
| ROCE |
|
0 | 0.6626 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
2/10
|
4.27 | 0.5873 | 627.04% | 4.76 | -10.23% |
| Nеt Debt/Ebitda |
|
3.23 | -1.27 | -354.13% |
|
|
| Debt/Ratio |
|
0.2627 | 0.1352 | 94.32% |
|
|
| Debt/Equity |
|
1.63 | 0.8667 | 87.83% |
|
|
| Debt/Net Income |
|
20.21 | 2.28 | 787.46% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
10/10
|
5.11 | 2.97 | 72.03% | 3.29 | +55.38% |
| Number of years of dividend growth |
|
3 | 1.26 | 137.93% | ||
| DSI |
|
0.8571 | 0.5452 | 57.21% |
|
|
| Average dividend growth |
|
12.81 | 8.21 | 56.09% |
|
|
| Average percentage for 5 years |
|
3.29 | 3.04 | 8.13% |
|
|
| Average percentage for payments |
|
23.24 | 34.24 | -32.12% |
|
|
| Difference from average difference in sector |
|
2.14 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
4/10
|
25.81 | 14.18 | 82.02% | ||
| Growth impulse Ebitda in 5 years |
|
3.23 | 64.12 | -94.96% | ||
| Growth impulse Net Income in 5 years |
|
-0.5194 | 22.8 | -102.28% | ||
| Growth impulse FCF in 5 years |
|
120.11 | 146.59 | -18.06% | ||
| Growth impulse EPS in 5 years |
|
0.3654 | -78.65 | -100.46% |
IP Score
5.27/10
